Chemotherapy and Radiation Versus Chemotherapy Alone for Elderly Patients With N3 Stage IIIB NSCLC.


Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI. Electronic address: [Email]


Standard treatment for stage III non-small-cell lung cancer (NSCLC) is concurrent chemotherapy and radiation (chemo-RT). However, N3 stage IIIB disease portends a worse prognosis and the tolerability of chemo-RT in patients ≥70 years old is a concern. In this analysis, we evaluate the survival of patients with N3 stage IIIB NSCLC who were treated with chemo-RT or chemotherapy alone with a focus on elderly patients.


Advanced age,Bimodality treatment,Chemo-RT,Non–small-cell lung cancer,Stage III,